GENINVO Part of PHUSE EU Connect & American Medical Writers Association (AMWA 2022) Event
GENINVO was a part of 2 recent global events for the life science industry. The 1st was "Premier Educational Event for Medical Communicators" organized by American Medical Writers Association “AMWA” which was held in Denver, CO. on 2nd – 5th November 2002 and the 2nd event, PHUSE EU Connect 2022 which was held in Northern Ireland, Belfast on 13th–16th November 2022. These even presented the best of industry insights and formed groundbreaking partnerships at events around the world.
- (1888PressRelease) December 15, 2022 - About PHUSE EU Connect: PHUSE EU Connect brought together our global community to collaborate on hot topics, share perspectives and discuss different approaches to guiding the healthcare industry landscape, both now and in the future. For more information, visit PHUSE — The Global Healthcare Data Science Community
Outcome: GENINVO had a fantastic experience & networking sessions with attendees. Our goal was to learn emerging trends, educate the industry on what we do, and we achieved it. We identified areas to further enhance our products to perfectly fit the needs of the industry. Our team produces transformational software solutions using years of experience in the life sciences. Our collaboration with industry forums, leading edge technologies, our software development capabilities, data-engineering, cloud expertise, and artificial intelligence knowledge has put us at the forefront for developing solutions for lifescience. It was a fantastic week of knowledge sharing and collaboration.
About American Medical Writers Association (AMWA 2022): The 2022 Medical Writing & Communication Conference program elevated health and well-being through medical communication field.
For more information, visit American Medical Writers Association (amwa.org)
Outcome: GENINVO had an incredible experience at AMWA 2022. The audience was impressed with our medical writing automation tool DocQC. DocQC machine learning and advanced quality checks will aid Medical Writers to focus more on scientific aspects.
In addition to DocQC the attendees were impressed learning about how easy it is to achieve data anonymization with our Health Canada & EMA policy 0070 compliant technology called Shadow, which also stood out in a winning position.
Message from CEO: “What a lovely year it has been! Our innovative solutions and services, along with our increased global presence has made 2022 a year to remember. In the coming years our team of technology and Subject Matter Experts will help GENINVO continue to grow. We will focus on collaborative initiatives, enhancement of our IP and will invest in new inventions to simplify our customers pain points. Thank you once again for being with us in 2022 and we look forward to even more success in 2023! May you and your families have a safe, healthy, and very happy holiday.” says Shweta Shukla, CEO at GENINVO.
About GENINVO: GENINVO is the go-to partner for those looking to better leverage technology in the life science industry. With expertise in life sciences, leading-edge technologies, and software development GENINVO can provide innovative solutions and services to its various sponsors. For more information, visit https://www.geninvo.com.
###
space
space
Contact Information
- Pragya Anand
- Geninvo
- c2, Vandana Vayushakti Appts, 8th Main, NRI Layout, Ramamurthy Nagar,
- 500084
- Voice: +918923026201
- Visit our Site
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam